Zhonghong Medical: Announcement about the subsidiary’s intention to participate in the centralized volume procurement project and be selected
Securities code: 300981 Securities abbreviation: Zhonghong Medical Announcement number: 2025-107
Zhonghong Pulin Medical Products Co., Ltd.
Announcement on the subsidiaries’ plans to be selected to participate in centralized volume procurement projects
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
Jiangxi Kelun Medical Equipment Manufacturing Co., Ltd. (hereinafter referred to as "Kelun Medical Equipment"), a holding subsidiary of Zhonghong Pulin Medical Supplies Co., Ltd. (hereinafter referred to as the "Company"), recently participated in the bidding for the quantity-price linked procurement project of medical consumables in Jiangxi Province. According to the announcement results of the first batch of volume-linked varieties of medical consumables in Jiangxi Province and the procurement demand, some products of Kelun Medical Equipment are planned to be selected for the above-mentioned centralized volume-based procurement projects. The relevant information is now announced as follows:
1. Basic information about the product to be selected
Proposed winning price Category of products to be supplied Model and specification of consumables Product and registration number Registration category Scope of application
Qualification and Quantity Selected Quantity for Disposable Infusion in Region
This product is suitable for intravenous retention
Disposable heparin cap not for public use
Used in conjunction with needle placement, it is the
For infusion HP-1 Category III Open, winning price Jiangxi Province
Fluid provides passage and injection
Heparin cap approved by National Machinery Industry, price 1.2 yuan/
Mouth.
20163141530
2. Impact on the company
The sales revenue of Kelun Medical Equipment's disposable heparin caps for infusion and other products in 2024 will be 2.0035 million yuan, accounting for 1.09% of Kelun Medical Equipment's operating income in 2024 and 0.08% of the company's operating income in 2024.
During the procurement cycle of Kelun Medical's above-mentioned products to be selected, medical institutions in the purchasing area will give priority to using the company's products to be selected and ensure that the agreed purchase volume is completed. After the subsequent purchase and sales contract is signed and implemented, it will be conducive to further expanding the market sales of the selected products, increasing market share, enhancing brand influence, and having a positive impact on the company's long-term development.
3. Risk warning
The purchase contract related to the products to be selected has not yet been signed, and subsequent events and the degree of impact on the company are uncertain. The company will pay close attention to the progress of this matter and fulfill its information disclosure obligations in a timely manner. Investors are advised to make prudent decisions and pay attention to investment risks.
Announcement hereby
Board of Directors of Zhonghong Pulin Medical Products Co., Ltd.
December 9, 2025